Is QURE a good stock to buy? We came across a bullish thesis on uniQure N.V. on r/stocks by AntoniaFauci. In this article, we will summarize the bulls’ thesis on QURE. uniQure N.V.'s share was trading at $20.68 as of May 4th. QURE’s trailing and forward P/E were 2.68 and 5.04 respectively according to Yahoo Finance.
[caption id="attachment_564437" align="aligncenter" width="750"]uniQure N.V. is a rare disease-focused biotech company developing gene therapies, highlighted by a breakthrough treatment for Huntington’s Disease, a fatal and...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.